PLSE Stock Analysis: Buy, Sell, or Hold?
PLSE - Pulse Biosciences, Inc Common Stock (DE)
$13.71
-0.12 (-0.87%)
▼
5d:
-4.26%
30d:
-0.15%
90d:
-18.85%
BUY
HIGH Confidence
Last Updated: February 2, 2026
Earnings: Mar 26, 2026
Get Alerted When PLSE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called PLSE this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PLSE shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: PLSE shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: PLSE is currently trading at $13.71, which is considered oversold relative to its 30-day fair value range of $13.76 to $14.68.
Technical Outlook: Technically, PLSE is in a strong downtrend. The price is currently testing key support at $13.30. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $22.00 (+60.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PLSE is in a strong downtrend. The price is currently testing key support at $13.30. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $22.00 (+60.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$13.76 -
$14.68
Company Quality Score
56/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 60.5% below Wall St target ($22.00)
Fair Price Analysis
30-Day Fair Range
$13.76 -
$14.68
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.94
(14.2%)
Support & Resistance Levels
Support Level
$13.30
Resistance Level
$15.34
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-8.26
Wall Street Target
$22.00
(+60.5%)
Last updated: February 02, 2026 9:39 PM ET
Data refreshes hourly during market hours. Next update: 10:39 PM
Data refreshes hourly during market hours. Next update: 10:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PLSE showing a specific setup today?
Insider Activity (6 Months)
1
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Patrick Danahy
SELL
4600 shares
2025-10-02
Kevin Patrick Danahy
SELL
400 shares
2025-09-19
Kevin Patrick Danahy
SELL
20000 shares
2025-09-18
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$612 | 57 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 59 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 56 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$297 | 57 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$91 | 62 BUY |
